Protara Therapeutics, Inc.

TARA

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001359931

SEC filings (opens in a new tab)

No open-market purchases or sales by Protara Therapeutics, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Protara Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of TARA: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Q4 2024	Change
Holders	35	60	+25
Shares	10.4M	29.7M	+19.2M (+184.0%)
Value	$19.1M	$156.6M	+$137.5M (+719.1%)

New holders (30)

Institutions that held Protara Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to TARA in Q4 2024
Institution	Shares	Value	% of portfolio
Janus Henderson Group PLC	2,271,832	$11.9M	0.01%
Adage Capital Partners GP, L.L.C.	2,250,000	$11.9M	0.02%
Toronto Dominion Bank	2,088,937	$11.0M	0.02%
Blackstone Group Inc.	1,680,000	$8.87M	0.04%
Sio Capital Management, LLC	1,437,500	$7.59M	2.14%
Integral Health Asset Management, LLC	1,400,000	$7.39M	0.65%
Acorn Capital Advisors, LLC	1,279,800	$6.76M	3.64%
Catalio Capital Management, LP	1,088,691	$5.75M	1.26%
5AM Venture Management, LLC	800,000	$4.22M	1.01%
Driehaus Capital Management LLC	517,152	$2.73M	0.02%
Superstring Capital Management LP	360,000	$1.90M	1.67%
Walleye Capital LLC	220,814	$1.17M	0.01%
Susquehanna International Group, LLP	218,473	$1.15M	0.00%
Goldman Sachs Group Inc	203,225	$1.07M	0.00%
BNP Paribas Arbitrage, SA	151,906	$802.1K	0.00%
J. Goldman & Co LP	141,748	$748.4K	0.03%
ADAR1 Capital Management, LLC	122,690	$647.8K	0.13%
Morgan Stanley	99,527	$525.5K	0.00%
Barclays PLC	93,239	$492.3K	0.00%
683 Capital Management, LLC	62,429	$329.6K	0.03%
Jane Street Group, LLC	37,734	$199.2K	0.00%
Gsa Capital Partners LLP	35,547	$188.0K	0.01%
Bailard, Inc.	29,769	$157.2K	0.00%
Dimensional Fund Advisors LP	20,997	$110.9K	0.00%
Squarepoint Ops LLC	20,755	$109.6K	0.00%
HBK Investments L P	20,000	$105.6K	0.00%
Citigroup Inc	12,945	$68.3K	0.00%
Group One Trading, L.P.	1,394	$7.36K	0.00%
SBI Securities Co., Ltd.	103	$544	0.00%
R Squared Ltd	30	$158	0.00%

Sold out (5)

Institutions that held Protara Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of TARA in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Boxer Capital, LLC	811,627	$1.49M
Two Sigma Advisers, LP	151,618	$277.5K
Marshall Wace, LLP	77,351	$141.6K
CIBC World Markets Inc.	28,000	$51.0K
Simplex Trading, LLC	373	$0